Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
暂无分享,去创建一个
E. Rofstad | T. Hompland | Berit Mathiesen | Einar K Rofstad | Kirsti Marie Øvrebø | Tord Hompland | B. Mathiesen | K. M. Øvrebø
[1] M. Alber,et al. Imaging oxygenation of human tumours , 2006, European Radiology.
[2] Nicholar E. Hagemeier,et al. A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites. , 1999, Microvascular research.
[3] J P Logue,et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[5] E. Rofstad,et al. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast‐enhanced magnetic resonance imaging , 2005, Journal of magnetic resonance imaging : JMRI.
[6] N. Hylton. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] E. Rofstad,et al. Magnetic resonance imaging of tumor necrosis , 2011, Acta oncologica.
[8] P. Vaupel,et al. Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.
[9] S. Rockwell,et al. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.
[10] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[11] E. Rofstad,et al. Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia. , 2010, Neoplasia.
[12] E. Rofstad,et al. Assessment of Fraction of Hypoxic Cells in Human Tumor Xenografts with Necrotic Regions by Dynamic Contrast-Enhanced MRI , 2008, Radiation research.
[13] E. Rofstad,et al. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. , 1999, International journal of radiation biology.
[14] Dag Rune Olsen,et al. Strategies for biologic image-guided dose escalation: a review. , 2009, International journal of radiation oncology, biology, physics.
[15] R K Jain,et al. Determinants of tumor blood flow: a review. , 1988, Cancer research.
[16] E. Rofstad,et al. Dynamic contrast‐enhanced‐MRI of tumor hypoxia , 2012, Magnetic resonance in medicine.
[17] E. Rofstad,et al. Quantitative assessment of hypoxia in melanoma xenografts by dynamic contrast-enhanced magnetic resonance imaging: intradermal versus intramuscular tumors. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] B. Fenton,et al. Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? , 1995, International journal of radiation oncology, biology, physics.
[19] M. Dewhirst,et al. Tumor oxygenation: a matter of supply and demand. , 1996, Anticancer research.
[20] E. Rofstad,et al. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[21] E. Rofstad,et al. Fluctuations in tumor blood perfusion assessed by dynamic contrast‐enhanced MRI , 2007, Magnetic resonance in medicine.
[22] P. López-Larrubia,et al. Imaging tumor hypoxia by magnetic resonance methods , 2011, NMR in Biomedicine.
[23] Kristine Gulliksrud,et al. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] P. Jakob,et al. Correlating quantitative MR measurements of standardized tumor lines with histological parameters and tumor control dose. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] E. Rofstad,et al. Assessment of tumor blood perfusion by high‐resolution dynamic contrast‐enhanced MRI: A preclinical study of human melanoma xenografts , 2004, Magnetic resonance in medicine.
[26] E. Rofstad,et al. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. , 2009, International journal of radiation oncology, biology, physics.
[27] E. Rofstad,et al. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] Evis Sala,et al. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. , 2007, The Lancet. Oncology.
[29] Jian Z. Wang,et al. Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical Cancer , 2009, Investigative radiology.
[30] E. Rofstad,et al. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling. , 2008, Magnetic resonance imaging.
[31] Kristine Gulliksrud,et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Tumors: Preclinical Validation of Parametric Images , 2009, Radiation research.
[32] M V Knopp,et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] M Recht,et al. Method for the quantitative assessment of contrast agent uptake in dynamic contrast‐enhanced MRI , 1994, Magnetic resonance in medicine.
[34] H Lyng,et al. Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd‐DTPA‐enhanced MR imaging , 2001, Journal of magnetic resonance imaging : JMRI.
[35] F. Gilbert,et al. A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer. , 2009, International journal of radiation oncology, biology, physics.
[36] D. Siemann,et al. Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[37] James L Tatum,et al. Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy , 2006, International journal of radiation biology.
[38] R. Hermans. Estimation of tumour oxygenation levels with dynamic contrast-enhanced magnetic resonance imaging. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[39] Daniela Thorwarth,et al. Implementation of hypoxia imaging into treatment planning and delivery. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.